Investing Profile

Paul Grayson

InvestorVC

Venture Partner at Versant Ventures

Your Intro Paths to Paul Grayson

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Paul is a member of

Stromedix Inc. Network

267 CONNECTIONS

Stromedix Inc. Network

267 CONNECTIONS

University of California, Los Angeles Network

224 CONNECTIONS

UCLA Network

146 CONNECTIONS

Versant Ventures Network

27 CONNECTIONS

Find Paul Grayson on

Current Investing Position

Versant Ventures Venture Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$102.2M

Paul Grayson is on these Sector & Stage Rankings

Paul Grayson's Investments On Record (3)

Company	StageDateRound Size	Total Raised
Tentarix Biotherapeutics	Series BSep 2023$35M Series AOct 2021$50M	$85M
Co-investors: Marcos Milla (Samsara BioCapital), Jerel Davis (Versant Ventures), Allyson Tighe (Amplitude Ventures)
Contineum Therapeutics	Series CFeb 2021$80M Series BDec 2019$32M	$110M
Co-investors: Clare Ozawa (Versant Ventures)
Taligen Therapeutics	Series BJan 2008$65M	$79M
Co-investors: Mark Lupa (Buff Gold Ventures)

Paul Grayson's Media (1)

Versant Ventures Announces Closing of $500 Million Venture Fund

www.fiercebiotech.com

Paul Grayson's Experience

Senior Vice President, Corporate Development Stromedix Inc.Present

Managing Director Sanderling VenturesPresent

President, CEO, Chairman and Founder Stromedix Inc.Present

President and CEO Fate Therapeutics Inc.Present

President and CEO Skye Bioscience Inc.Present

Venture Partner Versant VenturesPresent

President and CEO Tentarix BiotherapeuticsPresent

President and CEO Radionetics OncologyPresent

Paul Grayson's Education

University of California, Los Angeles BS Biochemistry and Computer Science

UCLA BS Biochemistry and Computer Science

Investors who invest with Paul Grayson

Scouts & Angels Affiliated With Paul Grayson